BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11774489)

  • 1. IFN-gamma secreted by virus-specific CD8+ T cells contribute to CNS viral clearance.
    Parra B; Bergmann CC; Hinton DR; Atkinson R; Stohlman SA
    Adv Exp Med Biol; 2001; 494():335-40. PubMed ID: 11774489
    [No Abstract]   [Full Text] [Related]  

  • 2. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells.
    Bergmann CC; Parra B; Hinton DR; Ramakrishna C; Dowdell KC; Stohlman SA
    J Virol; 2004 Feb; 78(4):1739-50. PubMed ID: 14747539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
    Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
    J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cell mediated immunity to neurotropic MHV infection.
    Bergmann CC; Marten NW; Hinton DR; Parra B; Stohlman SA
    Adv Exp Med Biol; 2001; 494():299-308. PubMed ID: 11774484
    [No Abstract]   [Full Text] [Related]  

  • 5. IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
    Parra B; Hinton DR; Marten NW; Bergmann CC; Lin MT; Yang CS; Stohlman SA
    J Immunol; 1999 Feb; 162(3):1641-7. PubMed ID: 9973424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IFN-gamma responsiveness in CD8 T-cell-mediated viral clearance and demyelination in coronavirus-infected mice.
    Templeton SP; Perlman S
    J Neuroimmunol; 2008 Feb; 194(1-2):18-26. PubMed ID: 18082272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute CNS infection is insufficient to mediate chronic T cell retention.
    Marten NW; Hohman M; Stohlman SA; Atkinson RD; Hinton DR; Bergmann CC
    Adv Exp Med Biol; 2001; 494():349-54. PubMed ID: 11774491
    [No Abstract]   [Full Text] [Related]  

  • 8. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.
    Bergmann CC; Altman JD; Hinton D; Stohlman SA
    J Immunol; 1999 Sep; 163(6):3379-87. PubMed ID: 10477608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced memory CD8+ T cells cannot prevent central nervous system virus reactivation.
    Ramakrishna C; Atkinson RA; Stohlman SA; Bergmann CC
    J Immunol; 2006 Mar; 176(5):3062-9. PubMed ID: 16493065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection.
    Marten NW; Stohlman SA; Zhou J; Bergmann CC
    J Virol; 2003 Feb; 77(4):2775-8. PubMed ID: 12552021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice.
    Haring JS; Pewe LL; Perlman S
    J Virol; 2001 Mar; 75(6):3043-7. PubMed ID: 11222733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of CD8+ T cells and viral spread to demyelinating disease.
    Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
    J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of primary and secondary CD8+ T cells in the central nervous system.
    Ramakrishna C; Stohlman SA; Atkinson RA; Hinton DR; Bergmann CC
    J Immunol; 2004 Nov; 173(10):6265-73. PubMed ID: 15528365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
    Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
    J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
    Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
    J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional.
    Kang BS; Lyman MA; Kim BS
    J Virol; 2002 Jul; 76(13):6577-85. PubMed ID: 12050370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system.
    Glass WG; Lane TE
    Virology; 2003 Aug; 312(2):407-14. PubMed ID: 12919745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of central nervous system viral persistence by neutralizing antibody.
    Ramakrishna C; Bergmann CC; Atkinson R; Stohlman SA
    J Virol; 2003 Apr; 77(8):4670-8. PubMed ID: 12663773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.
    Templeton SP; Perlman S
    Immunol Res; 2007; 39(1-3):160-72. PubMed ID: 17917063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D signaling and host defense after mouse hepatitis virus infection of the central nervous system.
    Walsh KB; Lodoen MB; Lanier LL; Lane TE
    Adv Exp Med Biol; 2006; 581():369-72. PubMed ID: 17037561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.